|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/12 | |
| A61K 31/443 | |||
| A61P 11/00 |
| (11) | Number of the document | 3339306 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16834669.0 |
| Date of filing the European patent application | 2016-08-11 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2016/094589 |
| Date | 2016-08-11 |
| (87) | Number | WO 2017/025045 |
| Date | 2017-02-16 |
| (30) | Number | Date | Country code |
| 201510489485 | 2015-08-11 | CN |
| (72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
LIU, Kai, CN
ZOU, Po, CN
ZHANG, Xiaoyu, CN
|
| (73) |
Crystal Pharmatech Co., Ltd.,
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | CRYSTAL FORM OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOLE-5-YL)CYCLOPROPANE FORMAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID AND PREPARATION METHOD THEREOF |
| CRYSTAL FORM OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOLE-5-YL)CYCLOPROPANE FORMAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID AND PREPARATION METHOD THEREOF |